Alzinova Presented at Aktiedagen
Date: 2021-05-17
At Aktiespararna's Aktiedagen on Monday, our CEO, Kristina Torfgård provided an update on Alzinova and progress on the first oligomer-specific, clinical study with a therapeutic vaccine in Alzheimer's patients.